Bristol Myers Squibb (BMY) Gross Profit (2016 - 2025)
Historic Gross Profit for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $8.4 billion.
- Bristol Myers Squibb's Gross Profit rose 1162.02% to $8.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $34.3 billion, marking a year-over-year decrease of 21.85%. This contributed to the annual value of $34.3 billion for FY2025, which is 21.55% down from last year.
- Latest data reveals that Bristol Myers Squibb reported Gross Profit of $8.4 billion as of Q4 2025, which was up 1162.02% from $8.8 billion recorded in Q3 2025.
- In the past 5 years, Bristol Myers Squibb's Gross Profit registered a high of $9.6 billion during Q4 2021, and its lowest value of $7.5 billion during Q4 2024.
- Moreover, its 5-year median value for Gross Profit was $8.8 billion (2022), whereas its average is $8.8 billion.
- As far as peak fluctuations go, Bristol Myers Squibb's Gross Profit skyrocketed by 2450.87% in 2021, and later tumbled by 1376.55% in 2024.
- Bristol Myers Squibb's Gross Profit (Quarter) stood at $9.6 billion in 2021, then dropped by 8.47% to $8.8 billion in 2022, then fell by 0.92% to $8.7 billion in 2023, then dropped by 13.77% to $7.5 billion in 2024, then rose by 11.62% to $8.4 billion in 2025.
- Its Gross Profit was $8.4 billion in Q4 2025, compared to $8.8 billion in Q3 2025 and $8.9 billion in Q2 2025.